CANNONE, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 1.352
AS - Asia 763
EU - Europa 578
OC - Oceania 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.701
Nazione #
US - Stati Uniti d'America 1.348
CN - Cina 428
IE - Irlanda 278
SG - Singapore 236
SE - Svezia 131
TR - Turchia 69
IT - Italia 43
DE - Germania 37
FI - Finlandia 24
BE - Belgio 16
TW - Taiwan 13
IN - India 11
GB - Regno Unito 10
FR - Francia 8
NL - Olanda 6
PL - Polonia 4
AT - Austria 3
CA - Canada 3
NZ - Nuova Zelanda 3
RO - Romania 3
UA - Ucraina 3
EG - Egitto 2
MD - Moldavia 2
NO - Norvegia 2
VN - Vietnam 2
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
LU - Lussemburgo 1
OM - Oman 1
PT - Portogallo 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 2.701
Città #
Dublin 277
Chandler 264
Singapore 185
Beijing 133
Ann Arbor 128
Ashburn 117
Dearborn 88
Nanjing 81
Boardman 78
Izmir 69
Princeton 61
Wilmington 42
Houston 40
Shanghai 29
Woodbridge 28
Kunming 27
Helsinki 24
Bremen 23
Seattle 22
Nanchang 19
Fremont 18
Brussels 16
Shenyang 16
Hebei 14
Jiaxing 14
Parma 13
Taipei 13
Tianjin 12
Changsha 11
Hefei 11
Santa Clara 11
Jinan 10
San Mateo 9
Guangzhou 8
Norwalk 8
Redmond 8
Rockville 7
Pune 6
Borås 5
Des Moines 5
Milan 5
Amsterdam 4
Dallas 4
Los Angeles 4
New York 4
Warsaw 4
Washington 4
Xian 4
Chengdu 3
Nürnberg 3
Vienna 3
Wenzhou 3
Bergamo 2
Cairo 2
Como 2
Dong Ket 2
Falls Church 2
Fuzhou 2
Hangzhou 2
Huzhou 2
Hyderabad 2
Jacksonville 2
Ningbo 2
Oderzo 2
Redwood City 2
Senigallia 2
Suri 2
Taiyuan 2
Tetchea 2
Trezzano Sul Naviglio 2
Turin 2
Apo 1
Arconate 1
Auckland 1
Baotou 1
Bologna 1
Bonnybridge 1
Bristol 1
Chongqing 1
Cincinnati 1
Clearwater 1
Clifton 1
Edinburgh 1
Enschede 1
Esslingen am Neckar 1
Fairfield 1
Fenghua 1
Forest City 1
Frankfurt am Main 1
Grafing 1
Haikou 1
Heathfield 1
Jinhua 1
Kish 1
Langfang 1
Las Vegas 1
Latisana 1
Lisbon 1
Luxembourg 1
Madrid 1
Totale 2.062
Nome #
Atrial natriuretic peptide: A molecular target of novel therapeutic approaches to cardio-metabolic disease 118
NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis 89
Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis 87
Electrolyte Disorders Induced by Antineoplastic Drugs 74
Posterior reversible encephalopathy syndrome in an oncological normotensive patient: Evidence for a pathogenic role of concomitant low magnesium serum levels and chemotherapy treatment 62
PRESENCE OF A NATRIURETIC PEPTIDE DEFICIENCY STATE AMONGST PATIENTS DIAGNOSED WITH HYPERTENSION 58
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: A 9-year follow-up study 56
Bisphosphonate-associated femoral fracture: Implications for management 55
Hypokalemic rhabdomyolysis in a patient with a laparoscopic adjustable gastric banding 54
DIFFERENTIAL REGULATION OF CIRCULATING CARDIAC NATRIURETIC PEPTIDES IN HUMAN ACUTE DECOMPENSATED HEART FAILURE: EVIDENCE FOR A SELECTIVE AND RELATIVE ATRIAL NATRIURETIC PEPTIDE DEFICIENCY 54
Association of NPPA rs5065 Genetic Variant With Increased Cardiovascular Risk in the General USA Population 52
Aging and oral health: Effects in hard and soft tissues 51
Aldosterone, Cardiorenal and Metabolic Disease in a General Community in Olmsted County, Minnesota: Biomarker and/or Mediator 51
The BNP genetic variant rs198389: cardiovascular phenotype and risk in stage A/B heart failure subjects from the STOP-HF Trial 50
Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: A 9-year follow-up study 49
Can a cardiac peptide predict mortality in human hypertension? 49
The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure 49
Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP 47
A cardiometabolic protective phenotype associated with the ANP genetic variant rs5068 in African Americans: the Multi-Ethnic Study of Atherosclerosis (MESA) 47
Aldosterone in the General Community: Biomarker or Mediator of Cardiorenal and Metabolic Disease 47
A cardio-metabolic phenotype in carriers of NPPA (rs5086) and NPPB (rs198389) gene variants in the general population: the dominant role of ANP 46
FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa 45
MANP: A Novel Designer Natriuretic Peptide for Cardiometabolic Disease 45
Metabolic disease in the general population: a potential cyclic GMP deficiency states 45
Circulating aldosterone predicts future cardiorenal and metabolic disease in the general community 45
CHARACTERIZATION OF ANP GENETIC VARIANT RS5068 IN CHRONIC HEART FAILURE PATIENTS 44
A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community 42
Aldosterone Level in the General Community Predicts New Onset Cardiometabolic Disease 42
Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population 42
An update on rickettsiosis 42
Mineral bone diseases and thermal walter therapy hot mud bath 40
Circulating cGMP Levels in the General Population: Relationship with Cardiovascular and Renal Diseases 40
Aldosterone predicts cardiovascular, renal, and metabolic disease in the general community: A 4-year follow-up 40
Aldosterone: Marker and Predictor of Cardiorenal and Metabolic Disease in the General Community 40
Evidence for a Prehypertensive Water Dysregulation Affecting the Development of Hypertension: Results of Very Early Treatment of Vasopressin V1 and V2 Antagonism in Spontaneously Hypertensive Rats 39
A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA) 39
The ANP Genetic Variant rs5068 Is Associated with Higher Circulating Concentrations of Natriuretic Peptides in Patients with Chronic Heart Failure 39
THE BNP GENETIC VARIANT RS198389: HYPERTENSION RISK AND CARDIOVASCULAR PHENOTYPE IN STAGE A AND STAGE B HEART FAILURE SUBJECTS FROM THE STOP-HF TRIAL 39
Chronic Renal Insufficiency: Prevalence in the General Population and Improved Detection of Cardiac Disease in Combination with BNP Assays 39
Plasma Aldosterone and Heart Failure in the General Community 38
The atrial natriuretic peptide genetic ariant rs5068 is associated with a favorable cardiometabolic phenotype in a mediterranean population 38
A Genetic Variant of the ANP Gene Is Associated With a Lower Cardiometabolic Risk Profile in the General USA Population 38
An atrial natriuretic peptide genetic variant (rs5065) in the general US population identifies risk for cerebrovascular accidents 37
IN-DEPTH PHENOTYPE OF SUBJECTS WITH INCREASED HEART FAILURE RISK BASED ON B-TYPE NATRIURETIC PEPTIDE 37
MANP: A novel designer natriuretic peptide GC-A activator for the treatment of hypertension and heart failure 36
Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: A metabolic link with the cardiac natriuretic pathway 35
Circulating aldosterone and natriuretic peptides in the general community relationship to cardiorenal and metabolic disease 34
Circulating cGMP plasma levels in cardiovascular and renal diseases: new insights from the general community 34
The Soluble Guanylate Cyclase Genetic Variant rs13139571 Is Associated with an “Unfavorable” Metabolic Phenotype in an US General Community 34
The malnutrition in the elderly: A clinical approach 33
Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure 32
Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis) 32
In Vitro and In Vivo Actions of a Novel ANP Genetic Variant: Unique Actions on Human Endothelial Cells 32
A genetic variant of the NPPA gene (rs5068) is associated with increased NT-ANP levels and reduced cardiometabolic risk 31
A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure 28
Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism 27
Evidence of autonomic dysregulation in otherwise healthy cancer caregivers: A possible link with health hazard 25
Circulating molecular forms of ANP and BNP in human acute decompensated heart failure: evidence for a relative ANP deficiency state 24
Necrotizing fasciitis of the face: A life-threatening condition 24
The role of OPG, RANK, RANKL in the bone metabolism, cardiovascular disease and immune system: Clinical and physiopathological implication 24
First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension 20
Circulating Corin in the General Community: A Link to Gender and Metabolic Phenotype 19
Circulating corin in the general community: link to gender and metabolic dysfunction 18
Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension 17
STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure 17
Natriuretic peptide pathways in heart failure: further therapeutic possibilities 12
Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation 9
Sex-based differences in metabolic protection by the ANP genetic variant rs5068 in the general population 5
MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease 5
Totale 2.787
Categoria #
all - tutte 14.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020306 0 0 0 0 16 88 44 40 38 46 26 8
2020/2021128 13 6 7 16 3 13 10 11 26 5 10 8
2021/2022224 7 7 4 4 7 2 17 28 11 13 9 115
2022/2023962 109 87 20 72 94 87 7 89 341 2 31 23
2023/2024353 29 34 14 13 41 71 16 34 17 22 31 31
2024/2025313 5 74 92 55 87 0 0 0 0 0 0 0
Totale 2.787